Table 1. Visual outcome before and after treatment for MG.
Parameters | LP | HM/near | CF/near | 0.02-<0.1 | 0.1-<0.3 | 0.3-<0.5 |
Baseline | ||||||
Medical therapy | 1 | 2 | 1 | |||
YAG | 2 | |||||
Vitrectomy group | 1 | 2 | 1 | 3 | 6 | 0 |
Phaco group | 1 | 1 | 2 | 2 | 3 | 1 |
Combination group | 1 | 1 | 2 | 4 | 1 | 0 |
Sub total | 3 | 4 | 6 | 11 | 13 | 1 |
End point | ||||||
Medical therapy | 1 | 1 | 2 | |||
YAG | 2 | |||||
Vitrectomy group | 1 | 2 | 1 | 3 | 3 | 3 |
Phaco group | 1 | 1 | 2 | 1 | 2 | 3 |
Combination group | 1 | 1 | 3 | 1 | 3 | 0 |
Sub total | 3 | 4 | 6 | 6 | 9 | 10 |
Baseline refers to the time of diagnosis of MG; End point refers to the final follow up. LP: Light perception; HM: Hand motion; CF: Counting figure.